1. Stocks
  2. Travere Therapeutics Inc
  3. Swot
swot-logo

Travere Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Travere Therapeutics Inc has 17 Strengths, 8 Weaknesses, 2 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Rising Momentum: Momentum Score Weekly Gainers

Companies with 10% increase in share price over three months, with rising net profit growth

Relative Outperformance versus Industry over 1 Week

Significant (over 30%) distance from 52 week high

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Relative Outperformance versus Industry over the Quarter (3 Months)

Relative Outperformance versus Industry over 1 Year

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Increasing Revenue every Quarter for the past 4 Quarters

Top Gainers

Stock with Low PE (PE < = 10)

RSI indicating price strength

Highest Recovery from 52 Week Low

Stocks Outperforming their Industry Price Change in the Quarter

Stocks with Quarter Change % less than Industry

Momentum Trap (DVM)

Companies with High Debt

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Risky Value (DVM)

Low durability companies

Companies with Increasing Debt

Low Piotroski Score : Companies with weak financials

Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts

Mutual Funds Increased Shareholding in Past Month

MFs decreased their shareholding last quarter

Promoters increasing shareholding QoQ

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks